D. Kummer

Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: an IPD meta-analysis.

U. Amstutz, J. Schellens, S. Aebi, 2019, Pharmacological research.

Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio.

A. V. van Kuilenburg, M. Joerger, C. Largiadèr, 2014, Pharmacogenomics.

Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early‐Onset Capecitabine‐Related Toxicity

U. Amstutz, S. Aebi, M. Joerger, 2017, Clinical pharmacology and therapeutics.

Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity.

U. Amstutz, S. Aebi, M. Joerger, 2015, Pharmacogenomics (London).